Form 4 for PRTA PROTHENA CORP PUBLIC LTD CO

Accepted 2022-07-29 00:00:00 ET · period of report 2022-07-27 · accession 0001140361-22-027528 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
D	2022-07-29	2022-07-27	PRTA	Kinney Gene G.	Pres, CEO	M - OptEx	$6.41	+376	13.2K	+3%	+$2,410
D	2022-07-29	2022-07-27	PRTA	Kinney Gene G.	Pres, CEO	S - Sale+OE	$32.00	-376	12.8K	-3%	-$12.0K
D	2022-07-29	2022-07-27	PRTA	Kinney Gene G.	Pres, CEO	M - OptEx	$0.00	-376	98.7K	-0.4%	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Ordinary Shares, par value $0.01 per share	2022-07-27	M	A	376	$6.41	13,169	D	—	—
2	Common	Ordinary Shares, par value $0.01 per share	2022-07-27	S	D	376	$32.00	12,793	D	—	—
3	Derivative	Stock Option (Right to Buy)	2022-07-27	M	D	376	$0.00	98,698	D	$6.41 · — to 2023-01-29	376 Ordinary Shares	(F3) The Reporting Person holds options that give him the right to acquire an aggregate of 2,103,398 shares at exercises prices ranging from $6.41 to $32.45, of which 1,571,938 are currently exercisable, and 531,460 are currently unexercisable but vest over time, subject to the Reporting Person's continued employment with the Issuer on each applicable vesting date of each option award. (F2) The option was granted on January 29, 2013 and all shares subject to the option were fully vested and exercisable. The option will expire in approximately six months and be forfeited to the extent it is not exercised on or prior to January 29, 2023.